Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • LIGAND PHARMACEUTICALS INC Analyst Recommendations

  • Analyst Consensus: LGND

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 3.000 Hold 1
    30 Days Ago 3.000 Hold 1
    60 Days Ago 3.000 Hold 1
    90 Days Ago 3.000 Hold 1
    120 Days Ago 2.000 Buy 1

  • Analyst Ratings: LGND

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Merriman Buy Neutral 08/04/2009 —
    Merriman Curhan Ford — Buy 02/11/2009 —
    Oppenheimer — Outperform 01/21/2009 5.00
    Rodman & Renshaw — Mkt Outperform 11/26/2008 5.00
    Broadpoint Capital — Buy 06/23/2008 6.00
    Susquehanna Financial — Positive 05/29/2008 7.00
    Susquehanna Financial — Positive 12/07/2007 —
    First Albany Neutral Buy 09/08/2006 —
    First Albany Buy Neutral 03/17/2006 —
    Friedman Billings Underperform Mkt Perform 01/18/2006 10.00
    First Albany — Buy 09/14/2005 9.50
    First Albany Neutral Buy 08/15/2005 10.00
    Wachovia Mkt Perform Outperform 07/15/2005 —
    Ferris Baker Watts Buy Neutral 03/28/2005 9.00
    UBS — Neutral 03/18/2005 8.00
    First Albany Neutral Buy 01/14/2005 —
    First Albany Buy Neutral 11/10/2004 8.50
    First Albany Neutral Buy 09/30/2004 —
    UBS — Neutral 09/24/2004 11.00
    Wachovia — Outperform 09/10/2004 —
    First Albany Buy Neutral 08/03/2004 13.00
    First Albany — Buy 07/06/2004 25.00
    First Albany — Buy 06/14/2004 25.00
    First Albany — Buy 06/07/2004 25.00
    First Albany — Buy 06/02/2004 —
    First Albany — Buy 06/01/2004 25.00
    Roth Capital — Buy 05/05/2004 25.00
    First Albany — Buy 04/12/2004 25.00
    Roth Capital — Buy 04/01/2004 27.00
    First Albany — Buy 03/29/2004 25.00
    Next